Заявка zPREDICTA в YC

Summer 2015Acquired

zPREDICTA прошел Y Combinator в потоке Summer 2015 как компания из сферы Healthcare. Ниже: чем занимается компания, кто ее основал, и ее заявка в YC, реконструированная вопрос за вопросом в реальной форме YC.

Поток YC: Summer 2015
Сфера: HealthcareDrug Discovery and Delivery
Размер команды: 2
Статус: Acquired
Запущено: 2015

Фаундеры

Mukti ParikhFounder/CTO

Чем занимается zPREDICTA

zPREDICTA is developing organ-specific, physiologically-relevant 3D cell culture models providing a 1-to-1 reconstruction of human tissues. This is the only available 3D culture approach that comprehensively accounts for the major components of the cellular and extracellular tissue microenvironment preserving the critical interactions between a tumor and its surroundings. Clinical study data demonstrate the high correlation between drug efficacy measured in our platform and the clinical response. The ability of the zPREDICTA platform to reliably predict clinical outcomes offers superior compound attrition management, empowering researchers to exclude ineffective compounds while selecting agents with a high probability of success in the clinic. Our approach is compatible with any drug class, multiple tissue/cell types and a wide variety of readouts. Our customers are using these models for efficacy screening of anticancer compounds, including immuno-oncology agents, evaluation of mechanisms of drug resistance, the rescue of failed drug candidates, assessment of off-target toxicity, and a multitude other applications.

Заявка zPREDICTA в YC, реконструирована

Заявка Y Combinator

zPREDICTA, батч Summer 2015. Реальные вопросы из анкеты, ответы из публичных данных.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

zPREDICTA

Describe what your company does in 50 characters or less.

Patient-derived 3D tissue models for drug testing

What is your company going to make? Please describe your product and what it does or will do.

We build organ-specific, physiologically relevant 3D cell culture models that reconstruct human tissues on a 1-to-1 scale. Our platform preserves interactions between tumors and their microenvironment, offering a better way to predict drug responses before clinical trials. Researchers use our models to screen anticancer compounds, study drug resistance, and evaluate toxicity.

Where do you live now, and where would the company be based after YC?

We live in San Jose, CA, and plan to keep the company based here after YC.

Explain your decision regarding location.

San Jose is where our labs and early operations are set up, and it's close to the biomedical ecosystem we rely on. Staying here means maintaining easy access to patient samples and collaborators.

21 еще ответ в полной заявке

Founders, Progress, Idea, Equity, Curious, Batch Preference находятся в полной версии. Создайте бесплатную учетную запись, чтобы открыть ее в YC Insights, рядом с каждым другим потоком YC.

Смотреть полную заявку

Часто задаваемые вопросы

Это реальная заявка zPREDICTA в YC?

Нет. Y Combinator держит поданные заявки в приватности. Это реконструкция: реальные вопросы формы YC, ответы на которые основаны на публичных данных zPREDICTA (заметки о запуске, бэкграунд фаундеров, описание продукта). Это показывает, как компания вроде zPREDICTA представила бы себя YC, а не текст, который они подали.